NBO Pharma Inc. files Form D for $7 million private offering
The Delaware pharmaceutical company has sold $238,000 toward a $7 million equity and warrant offering as of a November 9, 2026 filing with the SEC.
SEC filing
Latest
1 story
Sign inSign in1 story
The Delaware pharmaceutical company has sold $238,000 toward a $7 million equity and warrant offering as of a November 9, 2026 filing with the SEC.
SEC filing